Why the study?
Iron deficiency is common in heart failure and associated with worse outcomes, but the comparative benefits and practical management of iron supplementation needed evaluation.
Does iron supplementation improve outcomes in patients with heart failure and iron deficiency?
Does iron supplementation improve outcomes in patients with heart failure and iron deficiency?
Intravenous iron supplementation improves exercise capacity, quality of life, and reduces hospitalizations in heart failure patients with iron deficiency, whereas oral iron is less effective.
May support IV iron consideration in HF with iron deficiency; leaves open optimal formulation and need for definitive trials.
Iron deficiency is common in patients with heart failure and has been associated with worse outcomes, including increases in mortality, disease progression, and hospitalizations. As such, several studies have evaluated the role of iron supplementation in mitigating these risks. Evidence for the role of intravenous iron in improving exercise capacity, quality of life, and hospitalizations is promising, although the benefits of oral iron remain less clear. This review will evaluate the literature surrounding iron supplementation in heart failure and provide practical recommendations for its management.
No takes yet. Share an insight, caveat, or question.
Gale et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: